drugset / Trial / NCT00231530

A Study of the Safety and Efficacy of Topiramate in the Treatment of Obese, Type 2 Diabetes Patients on a Controlled Diet

NCT00231530

RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to determine the efficacy and safety of topiramate compared with placebo in obese, Type 2 diabetic patients on a controlled diet.

Timeline

Start
2001-01
Primary completion
Completion
2002-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Topiramate Small molecule 96 mg Oral
Subject Topiramate Small molecule 192 mg Oral